Form D · Biotechnology
Galecto, Inc.
Boston, MA · CIK 0001800315
Offering snapshot reported Nov 21, 2025 · SEC filing
- Reported sold
- $285M Offering amount: $285M
- Investors reported
- 48 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 12, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 21, 2025 | Initial | $285,000,000 | No comparison | 48 | SEC filing |
| Nov 5, 2020 | Initial | $64,199,679 | No comparison | 42 | SEC filing |
| Jan 16, 2020 | Initial | $79,143,223 | No comparison | 35 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $17.1M
- Form D file number
- 021-564756
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Jefferies LLC | 2347 | |
| Leerink Partners LLC | 39011 | |
| UBS Securities LLC | 7654 | |
| LifeSci Capital, LLC | 168404 |
Source: Form D, filed Nov 21, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Julianne Bruno | Director |
| Christopher Cain | Director |
| Erez Chimovits | Director |
| Stephan Christgau | Director |
| Jayson Dallas | Director |
| Lori Firmani | Executive |
| Jon Freve | Executive |
| Carl Goldfischer | Director |
| Jakob Dynnes Hansen | Executive |
| Peter Harwin | Director |
| Chao Q. Khuong | Director |
| Soren Lemonius | Director |
| Chandra Leo | Director |
| Soren Moller | Director |
| Amit Munshi | Director |
| Hans T. Schambye | Director, Executive |
| David Shapiro | Director |
| Karen Wagner | Director |
| Garrett Winslow | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
75 State Street Suite 100
Boston, MA, 02109
Boston, MA, 02109